Optimal Candidates for
Cardiac Rhythm Devices
in heart failure
SIRIN APIYASAWAT, MD
RAMATHIBODI   HOSPITAL

heartrhythmbox.com

        
   feel
     Better
   live
     Longer
Diuretics, Inotropes       check_circle       cancel
ACEI, ARNI,
BB, MRA
      ?       check_circle
CRT
Cardiac Resynchronization Therapy
      check_circle       check_circle
format_quote
ก่อนที่เราจะไปถึงจุดนั้น...
เรามาทำความรู้จักกับ 'CRT' กันหน่อยดีมั้ย
CRT Overview...in 20 seconds.
format_quote
แล้วใครบ้าง
ที่จะได้ประโยชน์จาก CRT
Benefits of CRT by QRS duration
QRS<130 LBBB: QRS≥130 non-LBBB: QRS≥150
Benefits of CRT by NYHA & LVEF
Data on NYHA I was from MADIT-CRT. Data on NYHA II-IV was from the same meta-analysis.
format_quote
ขอสรุป สรุป...หน่อยสิ
Current Indications for CRT
QRS duration and morphology
QRS<130 LBBB: QRS≥130 non-LBBB: QRS≥150
NYHA
NYHA I if LBBB with QRS≥150 NYHA II-ambulatory IV
LVEF
LVEF≤35% HF with anticipated RV pacing of >40%
format_quote
แล้วเมื่อไหร่ต้องใส่ CRT-D
เมื่อไหร่ใส่แค่ CRT-P ก็พอ
Current class I indications for ICD for primary prevention of sudden cardiac arrest
ConditionsLVEFNYHATrials
Ischemic;
>40d post MI or >90d post revascularization
≤30%I-III MADIT II
Stable HF; ischemic or non-ischemic ≤35%II-III SCD-HeFT
Recent MI, NSVT, +EP Study ≤40%Any MUSTT
Rates of sudden cardiac death declined substantially over time.

Benefits of ICD by Seatle Heart Failure Model
What is Seatle Heart Failure Model?
Model to evaluate risks for... ×
The Seattle Heart Failure Model (SHFM) is a calculator of projected survival at baseline and after interventions for patients with heart failure.
The Seattle Proportional Risk Model (SPRM) is a calculator of estimated proportion of sudden death in patients with heart failure with reduced ejection fraction (primarily EF≤35%) to illustrate the variable the benefit of a primary prevention ICD.
format_quote
มี devices อื่นอีกมั้ย
(ถึงไม่เคยใช้...ก็พูดได้ไม่ใช่เหรอ)
Wearable ICD
Reasonable as a bridge to transplantation or re-implantation due to transient interruption such as infection.
May be considered as bridging therapy in situations associated with increased risk of death in which ICDs have been shown to reduce SCD but not overall survival such as within 40 days of MI.

Cardiac Contractility Modulation
A device-based therapy for heart failure (HF) that involves applying biphasic electric signals to the right ventricular septal wall during the absolute myocardial refractory period.
Been shown to improve quality of life in those with LVEF 35-45% and narrow QRS.
CONCLUSIONS
  • LVEF, NYHA class, and QRS duration remain the major indicators for cardiac rhythm devices in heart failure.

  • Age, sex, etiology, and comorbidities can further delineate who would be most beneficial from device therapy.